Endothelium, heal thyself: A fresh look at this resilient, adaptable tissue
(Medical Xpress)—The endothelium, the cellular layer lining the body's blood vessels, is extremely resilient. Measuring just a few hundred nanometers in thickness, this super-tenuous structure routinely ...
Medical research
May 16, 2013 |
4 / 5 (2) |
1
|
First prospective trial shows molecular profiling timely for tailoring therapy
A clinical trial has shown that patients, and their physicians, are eager to jump into next-era cancer care—analysis of an individual's tumor to find and target genetic mutations that drive the cancer. Results of the study, ...
Cancer
May 15, 2013 |
not rated yet |
0
Scientists develop 'magic bullet' nanomedicine for Acute Lung Injury
Researchers at Queen's University Belfast have devised a 'magic bullet' nanomedicine which could become the first effective treatment for Acute Lung Injury or ALI, a condition affecting 20 per cent of all patients in intensive ...
Medical research
May 15, 2013 |
4 / 5 (1) |
0
Thoracic endografts used successfully to remove tumors invading the aorta
Tumors have the potential to grow locally and invade neighboring organs. Some chest tumors may invade one of the great vessels of the body, the aorta. Surgical removal of these tumors is very challenging and necessitates ...
Cardiology
May 08, 2013 |
not rated yet |
0
Diabetes drug makes lung cancer vulnerable to radiotherapy
The diabetes drug metformin slows the growth of lung cancer cells and makes them more likely to be killed by radiotherapy, according to a study published in the British Journal of Cancer today.
Cancer
May 01, 2013 |
5 / 5 (2) |
0
How some cancers 'poison the soil' to block metastasis
Cancer spread or metastasis can strike unprecedented fear in the minds of cancer patients. The "seed and the soil" hypothesis proposed by Stephen Paget in 1889 is now widely accepted to explain how cancer cells (seeds) are ...
Cancer
Apr 30, 2013 |
5 / 5 (1) |
0
Chemo, radiation followed by surgery improves survival in lung cancer patients
In one of the largest observational studies of its kind, researchers report that a combination of chemotherapy and radiation followed by surgery in patients with stage 3 non-small cell lung cancer improves survival.
Cancer
Apr 30, 2013 |
not rated yet |
0
Cell response to new coronavirus unveils possible paths to treatments
NIH-supported scientists used lab-grown human lung cells to study the cells' response to infection by a novel human coronavirus (called nCoV) and compiled information about which genes are significantly disrupted ...
Diseases, Conditions, Syndromes
Apr 30, 2013 |
5 / 5 (1) |
0
Tactics of new Middle East virus suggest treating by altering lung cells' response to infection
A new virus that causes severe breathing distress and kidney failure elicits a distinctive airway cell response to allow it to multiply. Scientists studying the Human Coronavirus-Erasmus Medical Center, which ...
Diseases, Conditions, Syndromes
Apr 30, 2013 |
5 / 5 (1) |
0
|
Researchers observe an increased risk of cancer in people with history of non-melanoma skin cancer
A prospective study by researchers at Brigham and Women's Hospital (BWH) observed an association between risk of second primary cancer and history of non-melanoma skin cancer in white men and women.
Cancer
Apr 23, 2013 |
not rated yet |
0
Study suggests patients with lung cancer who carry specific HER2 mutations may benefit from certain anti-HER2 treatments
New results from a retrospective study conducted in Europe suggest that anti-HER2 treatments, like the widely used breast cancer agent trastuzumab (Herceptin), have anti-cancer effects in a small subset of patients with advanced ...
Cancer
Apr 22, 2013 |
not rated yet |
0
New ablation technique holds promise for liver cancer patients
A new minimally invasive tumor ablation technique is providing hope for liver cancer patients who can't undergo surgery or thermal ablation, a study shows.
Cancer
Apr 18, 2013 |
not rated yet |
0
Mast cells have critical role in initializing pulmonary fibrosis
Pulmonary fibrosis is a chronic, deadly disease that affects five million people worldwide. It is irreversible, its cause is poorly understood, and it has a median survival of only about 3 years. A new study ...
Medical research
Apr 11, 2013 |
not rated yet |
0
Researchers identify novel approach to study COPD and treatment efficacy
(Medical Xpress)—Researchers from Boston University School of Medicine (BUSM) have pinpointed a genetic signature for chronic obstructive pulmonary disease (COPD) from airway cells harvested utilizing a minimally invasive ...
Diseases, Conditions, Syndromes
Apr 11, 2013 |
not rated yet |
0
Engineered antibody demonstrated safety, efficacy in wide range of advanced tumors
(Medical Xpress)—The engineered antibody MPDL3280A, which targets a protein called programmed death-ligand 1 (PD-L1), was safe and effective for several cancers, according to phase I study results presented at the AACR ...
Cancer
Apr 10, 2013 |
4 / 5 (1) |
0
